These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10703589)
1. [Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders]. Fauser BC; Laven JS; de Jong D; Macklon NS Ned Tijdschr Geneeskd; 2000 Feb; 144(8):370-4. PubMed ID: 10703589 [TBL] [Abstract][Full Text] [Related]
2. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial. Vuong TN; Phung HT; Ho MT Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329 [TBL] [Abstract][Full Text] [Related]
4. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [TBL] [Abstract][Full Text] [Related]
5. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846 [TBL] [Abstract][Full Text] [Related]
6. The role of gonadotropin-releasing hormone antagonists in in vitro fertilization. Diedrich K; Ludwig M; Felberbaum RE Semin Reprod Med; 2001 Sep; 19(3):213-20. PubMed ID: 11679902 [TBL] [Abstract][Full Text] [Related]
7. Developments in drugs for ovarian stimulation. Ludwig M; Westergaard LG; Diedrich K; Andersen CY Best Pract Res Clin Obstet Gynaecol; 2003 Apr; 17(2):231-47. PubMed ID: 12758097 [TBL] [Abstract][Full Text] [Related]
8. Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor. Okada Y; Murota-Kawano A; Kakar SS; Winters SJ Biol Reprod; 2003 Oct; 69(4):1356-61. PubMed ID: 12801988 [TBL] [Abstract][Full Text] [Related]
9. Novel peptides in ovarian follicular fluid: implications for contraceptive development. Schwartz NB Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632 [TBL] [Abstract][Full Text] [Related]
13. Cortisol regulates secretion and pituitary content of the two gonadotropins differentially in female rats: effects of gonadotropin-releasing hormone antagonist. Ringstrom SJ; Suter DE; Hostetler JP; Schwartz NB Endocrinology; 1992 Jun; 130(6):3122-8. PubMed ID: 1597133 [TBL] [Abstract][Full Text] [Related]
14. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010 [TBL] [Abstract][Full Text] [Related]
15. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. Hall JE; Brodie TD; Badger TM; Rivier J; Vale W; Conn PM; Schoenfeld D; Crowley WF J Clin Endocrinol Metab; 1988 Sep; 67(3):524-31. PubMed ID: 3137243 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389 [TBL] [Abstract][Full Text] [Related]
17. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female. Schally AV Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624 [TBL] [Abstract][Full Text] [Related]
18. Comparative response of rams and bulls to long-term treatment with gonadotropin-releasing hormone analogs. Jiménez-Severiano H; D'Occhio MJ; Lunstra DD; Mussard ML; Davis TL; Enright WJ; Kinder JE Anim Reprod Sci; 2007 Apr; 98(3-4):204-24. PubMed ID: 16616998 [TBL] [Abstract][Full Text] [Related]
19. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation. Christin-Maitre S; Olivennes F; Dubourdieu S; Chabbert-Buffet N; Charbonnel B; Frydman R; Bouchard P Clin Endocrinol (Oxf); 2000 Jun; 52(6):721-6. PubMed ID: 10848876 [TBL] [Abstract][Full Text] [Related]
20. Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for in vitro fertilization. Orvieto R; Laufer N Fertil Steril; 2014 Nov; 102(5):1254-5. PubMed ID: 25282471 [No Abstract] [Full Text] [Related] [Next] [New Search]